Kaya Holdings (KAYS) Consolidated Net Income (2011 - 2025)
Kaya Holdings (KAYS) recorded quarterly Consolidated Net Income of -$1123.0 in Q1 2025, down 101.73% quarter-over-quarter from $64796.0 in Q4 2024, and up 98.12% on a YoY basis from -$566.83 in Q1 2024.
Kaya Holdings (KAYS) Consolidated Net Income (2011 - 2025) Analysis & Trends
Kaya Holdings' Consolidated Net Income history runs 15 years deep, the most recent figure standing at -$1123.0 for Q1 2025.
- In Q1 2025, Consolidated Net Income rose 98.12% year-over-year to -$1123.0; the TTM figure through Sep 2025 stood at $63673.0 (up 140.82% YoY), while the FY2024 annual figure was -$154076.0, down 212.82% from the prior year.
- Consolidated Net Income was -$1123.0 for Q1 2025 at Kaya Holdings, down from $64796.0 in the prior quarter.
- In the past five years, Consolidated Net Income ranged from a high of $9.2 million in Q2 2021 to a low of -$13.1 million in Q4 2021.
- Historically, Consolidated Net Income has averaged -$462182.4 across 5 years, with a median of -$1123.0 in 2025.
- Biggest YoY gain for Consolidated Net Income was 744.03% in 2021; the steepest drop was 739.23% in 2021.
- A 5-year view of Consolidated Net Income shows it stood at -$13.1 million in 2021, then surged by 113.73% to $1.8 million in 2022, then sank by 96.67% to $60080.0 in 2023, then climbed by 7.85% to $64796.0 in 2024, then sank by 101.73% to -$1123.0 in 2025.
- The last three Consolidated Net Income figures came in at -$1123.0 (Q1 2025), $64796.0 (Q4 2024), and -$97634.0 (Q3 2024), per Business Quant data.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Consol Net Inc. (Qtr) |
|---|---|---|---|---|---|
| 1 | Teva Pharmaceutical Industries | 39.72 Bn | 35.98 Bn | 1.97 Bn | 370.00 Mn |
| 2 | Zoetis | 34.61 Bn | 32.67 Bn | 1.62 Bn | 601.00 Mn |
| 3 | United Therapeutics | 24.07 Bn | 21.91 Bn | 648.10 Mn | 274.90 Mn |
| 4 | Aurora Cannabis | 16.98 Bn | 16.91 Bn | 33.43 Mn | -114,733.81 |
| 5 | Neurocrine Biosciences | 16.64 Bn | 15.32 Bn | 800.70 Mn | 197.90 Mn |
| 6 | Elanco Animal Health | 12.19 Bn | 11.76 Bn | 785.00 Mn | 57.00 Mn |
| 7 | Alkermes | 7.37 Bn | 6.86 Bn | -116.06 Mn | -66.53 Mn |
| 8 | Hims & Hers Health | 6.62 Bn | 5.87 Bn | 396.79 Mn | -92.12 Mn |
| 9 | Lantheus Holdings | 6.47 Bn | 5.97 Bn | 230.92 Mn | 118.42 Mn |
| 10 | Kaya Holdings | - | - | 5,370.00 | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2025 | -1,123.00 |
| Dec 31, 2024 | 64,796.00 |
| Sep 30, 2024 | -97,634.00 |
| Jun 30, 2024 | -58,663.00 |
| Mar 31, 2024 | -59,756.00 |
| Dec 31, 2023 | 60,080.00 |
| Sep 30, 2023 | 2.10 Mn |
| Jun 30, 2023 | -714,156.00 |
| Mar 31, 2023 | 34,933.00 |
| Dec 31, 2022 | 1.80 Mn |
| Sep 30, 2022 | -7.44 Mn |
| Jun 30, 2022 | 3.07 Mn |
| Mar 31, 2022 | -1.10 Mn |
| Dec 31, 2021 | -13.13 Mn |
| Sep 30, 2021 | 3.95 Mn |
| Jun 30, 2021 | 9.18 Mn |
| Mar 31, 2021 | -5.52 Mn |
| Dec 31, 2020 | 3.38 Mn |
| Sep 30, 2020 | -13.40 Mn |
| Jun 30, 2020 | -1.42 Mn |